Clinical Trial Details
— Status: Completed
Administrative data
NCT number |
NCT05481970 |
Other study ID # |
opioid free anesthesia |
Secondary ID |
|
Status |
Completed |
Phase |
N/A
|
First received |
|
Last updated |
|
Start date |
September 1, 2022 |
Est. completion date |
November 5, 2023 |
Study information
Verified date |
July 2022 |
Source |
Fayoum University Hospital |
Contact |
n/a |
Is FDA regulated |
No |
Health authority |
|
Study type |
Interventional
|
Clinical Trial Summary
Using opioids in the clinical practice of anesthesia was astonishing. They are good
analgesics and used widely to modulate perioperative pain, but analgesia with these drugs can
be associated with many side effects that may lead to prolongation of hospital stay and
recovery period like respiratory depression, delirium, impaired gastrointestinal function,
urine retention, post-operative nausea and vomiting (PONV), and addiction. The most
significant opioid side effect is respiratory depression. This is especially important in
patients suffering from obesity. Obese patients already have a restrictive lung disease
leading to decrease in functional residual capacity and total lung compliance. Anesthetics
and analgesics specially opioids make these respiratory problems become worse with increasing
the incidence of hypoxia. These side effects can be avoided by using opioid free anesthesia
(OFA) techniques.
Opioid free anesthesia recently become more applicable and popular in different centers, it
provides pain control with marked reduction in opioid consumption. However, researches and
studies still unable to explore definite explanations or techniques regarding it. The base of
OFA is that not only one drug can replace opioids. It is a multimodal anesthesia. Multiple
drugs are used to achieve it. They are hypnotics,N-methyl-D-aspartate (NMDA) antagonists
(ketamine, magnesium sulfate), sodium channel blockers (local anesthetics), anti-inflammatory
drugs (NSAID, dexamethasone), and alpha-2 agonists (dexmedetomidine, clonidine). Regional
anesthesia and nerve blocks also have a role. In this study, using OFA the investigators are
hoping to achieve a good quality of care to obese patients helping in fast track surgery with
less complications and so shorter period of hospital stay
Description:
Patients will be randomly allocated (by closed envelope method) to two groups:
Group A (n=38) will have opioid free anesthesia (OFA) Group B (n=38) will have opioid based
anesthesia (OPA) All patients will be subjected to a preoperative clinical examination and
routine preoperative laboratory investigations. Patients also will be trained on how to deal
with the VAS score before surgery. The visual analog scale (VAS) is a pain score using a
10-cm line with two ends "no pain" on the left end and the "worst pain" on the right end,
used to track pain for a patient or to compare pain between patients.(9,10) In the operating
room (OR), peripheral oxygen saturation (spo2), noninvasive blood pressure and
electrocardiogram ( ECG) will be monitored and recorded as a baseline reading. A peripheral
intravenous cannula will be inserted t hen patients in both groups will receive 1mg of
midazolam prior induction of anesthesia. Preoxygenation 3-5 minutes before induction will be
done. Group (A): Induction of general anesthesia will be done using lidocaine (1.5 mg/kg),
propofol (2-3 mg/kg), and atracurium (0.5 mg/kg). Dexmedetomidine 0.5 µg/kg over 10 min,
started 10 min before induction. Following tracheal intubation, dexmedetomidine infusion
generally will be initiated at 0.6 μg/kg/h and titrated between 0.2 and 1.0 μg/kg/h according
to the heart rate maintaining bispectral index (BIS) between 40-60, lidocaine (1.5 mg/kg/h).
ketamine will be given as a bolus dose of 0.3 mg/kg after induction and prior to skin
incision then 0.2 mg/kg/h as an infusion. Patients will receive dexamethasone (8 mg i.v.)
after induction. In group (B) for induction of anesthesia, patients will receive propofol
2-3mg/kg, fentanyl 1-2mcg/kg and atracurium 0.5 mg/kg as a muscle relaxant to facilitate
intubation. Fentanyl bolus doses of 0.5-1 mcg/kg will be given to keep BIS score 40-60 during
surgery.
All Patients will be mechanically ventilated with 50% O2 and 50% air and the end-tidal carbon
dioxide( CO2) will be maintained between 30 - 35 mmHg. Anesthesia will be maintained by
isoflurane and atracurium 0.1-0.2 mg/kg every 20-30 minutes. Reversal of muscle relaxants
will done by using intravenous neostigmine (0.05 mg/kg) and atropine (0.01 mg/kg) at the end
of surgery and the patient will be extubated when the patient will be able to breath
spontaneously with tidal volume ≥5ml/kg and spo2>92%. Paracetamol 1gm i.v. infusion and
ketorolac 30 mg slow i.v injection will be used at the end of surgery and before emergence in
both groups. At the recovery room, patients will assess their pain and rating it using VAS
score, monitored for postoperative pain, the patients will leave the post anesthesia care
unit (PACU) with Aldrete score more than 9. (11) Any patient with Vas score ≥4, will receive
tramadol 1mg/kg i.v. with a maximum dose 600mg/day.